http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0232460-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_561f9f3212384a6df75d7d7fa30cde4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ade2ad23e26cd06166c0ddfb0a419993
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2001-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16ae3aaed2a50d94714022fd19f5d21b
publicationDate 2002-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0232460-A1
titleOfInvention Use of biologically degradable substituted hydrocarbons, the esters, ethers and /or amides thereof for prophylaxis of allergic inhalation reactions and/or for treatment of the nasal mucosa
abstract The invention relates to the use of preparations for the prophylaxis of allergic inhalation reactions and/or for treatment of the nasal mucosa, comprising OH- and/or COOH-substituted hydrocarbons, the derivatives, esters, ethers and/or amides thereof, which are enzymatically degraded in the nasal mucosa or generally in the body and are physiologically acceptable.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2316415-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2283805-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2316415-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2425842-A1
priorityDate 2000-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62209023-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0352412-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62209016-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06256119-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128150736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11652328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID169203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128544380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127406230

Total number of triples: 42.